Valerie Heong

6PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.

Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu

|May 16, 2023
PARP Inhibitors in Breast and Ovarian Cancer.

Samuel S Y Wang, Yeo Ee Jie, Sim Wey Cheng

|Jul 29, 2021
A multi-ethnic analysis of immune-related gene expression signatures in patients with ovarian clear cell carcinoma.

Valerie Heong, Tuan Z Tan, Maiko Miwa

|Sep 29, 2020
First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.

Timothy A Yap, David S P Tan, Angelika Terbuch

|Jun 21, 2020
Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique.

Valerie Heong, Darwin Tay, Shane Ee Goh

|Dec 29, 2016
Update on immune checkpoint inhibitors in gynecological cancers.

Valerie Heong, Natalie Ngoi, David Shao Peng Tan

Pageof 1

Frequent Collaborators

4 joint publications

David Sp Tan

2 joint publications

Natalie Y L Ngoi

2 joint publications

Tuan Zea Tan

1 joint publications

Samuel S Y Wang